Evidence map›Paper›PMID 36438274›Full record

ArticleFrontiers in public health2022

Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.

Jeanne Goupil de Bouillé, Liem Binh Luong Nguyen, Pascal Crépey, Ronan Garlantezec, Véronique Doré, Audrey Dumas, Mohamed Ben Mechlia, Pierre Tattevin, Jean Gaudart, Bruno Spire and 5 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05311865 (Transmission of Covid-19 During Clubbing Events in Closed Places), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05311865 nacompletednot on this map

Transmission of Covid-19 During Clubbing Events in Closed Places

TypeinterventionalSponsorANRS, Emerging Infectious DiseasesRan2021 to 2022Enrolled1,216ConditionsHealthy ParticipantArmsClub event
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Lessons Learned from In-Person Conferences in the Times of COVID-19.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

Jeanne Goupil de BouilléService de Maladies Infectieuses et Tropicales, Hôpital Avicenne, AP-HP, Bobigny, France.
Liem Binh Luong NguyenCIC Cochin Pasteur, AP-HP, Paris, France.
Pascal CrépeyUniv Rennes, EHESP, CNRS, INSERM, Arènes - UMR 6051, RSMS - U 1309, Rennes, France.
Ronan GarlantezecCHU de Rennes, University Rennes, INSERM, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.
Véronique DoréANRS, Agence Nationale Recherche Sida, Paris, France.
Audrey DumasANRS, Agence Nationale Recherche Sida, Paris, France.
Mohamed Ben MechliaANRS, Agence Nationale Recherche Sida, Paris, France.
Pierre TattevinInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Jean GaudartAix Marseille University, APHM, INSERM, IRD, SESSTIM, ISSPAM, UMR1252, Hop Timone, BioSTIC, Biostatistic and ICT, Marseille, France.
Bruno SpireAix Marseille University, APHM, INSERM, IRD, SESSTIM, ISSPAM, UMR1252, Marseille, France.
France LertANRS, Agence Nationale Recherche Sida, Paris, France.
Yazdan YazdanpanahANRS, Agence Nationale Recherche Sida, Paris, France.
Constance DelaugerreService de Virologie, Hôpital Saint-Louis, AP-HP, INSERM U944, Université de Paris, Paris, France.
Marion NoretRenarci, Centre Hospitalier, Annecy, France.
Jeremy ZeggaghService de Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, AP-HP, Paris, France.
Agence Nationale de la Recherche · FRAssistance Publique – Hôpitaux de Paris · FRInstitut de Recherche pour le Développement · FRAgence Nationale de Recherches sur le Sida et les Hépatites Virales · FRCentre Hospitalier Annecy Genevois · FRCentre Hospitalier Universitaire de Rennes · FRÉcole des Hautes Études en Santé Publique · FRHôpital Pontchaillou · FRHôpital Saint-Louis · FRUniversité Sorbonne Paris Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The SARS-CoV-2 pandemic led to the implementation of several non-pharmaceutical interventions (NPIs), from closings of bars and restaurants to curfews and lockdowns. Vaccination campaigns started hoping it could efficiently alleviate NPI. The primary objective of the "Indoor Transmission of COVID-19" (ITOC) study is to determine among a fully vaccinated population the relative risk of SARS-CoV-2 transmission during one indoor clubbing event. Secondary objectives are to assess the transmission of other respiratory viruses, risk exposure, and attitudes toward COVID-19 vaccination, health pass, and psychological impact of indoor club closing. Methods and analysis: Four thousand four hundred healthy volunteers aged 18-49 years and fully vaccinated will be included in Paris region. The intervention is an 8-hour indoor clubbing event with no masks, no social distance, maximum room capacity, and ventilation. A reservation group of up to 10 people will recruit participants, who will be randomized 1:1 to either the experimental group (2,200 volunteers in two venues with capacities of 1,000 people each) or the control group (2,200 volunteers asked not to go to the club). All participants will provide a salivary sample on the day of the experiment and 7 days later. They also will answer several questionnaires. Virological analyses include polymerase chain reaction (PCR) of salivary samples and air of the venue, investigating SARS-CoV-2 and 18 respiratory viruses. Ethics and dissemination: Ethical clearance was first obtained in France from the institutional review board (Comité de Protection des Personnes Ile de France VII - CPP), and the trial received clearance from the French National Agency for Medicines and Health Products (Agence National de Sécurité du Médicament - ANSM). The trial is supported and approved by The Agence Nationale Recherche sur le SIDA, les hépatites et maladies émergences (ANRS-MIE). Positive, negative, and inconclusive results will be published in peer-reviewed scientific journals. Trial registration number: IDR-CB 2021-A01473-38. Clinicaltrial.gov, identifier: NCT05311865.

Indexed as

COVID-19SARS-CoV-2Communicable Disease ControlCOVID-19 VaccinesHumansMulticenter Studies as TopicPhysical DistancingRandomized Controlled Trials as TopicCOVID-19 Vaccinesnightclubrespiratory virusrespiratory virus transmissionSARS-CoV-2vaccine

Identifiers

PMID36438274
PMCPMC9687087
OpenAlexW4308331921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.